RTX Corp: Form 10-Q for the period ended Mar 31, 2019
Filed with the SEC on Apr 26, 2019 and accepted by EDGAR at Apr 26, 2019, 07:11 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2019-01-01 to 2019-03-31 | $18.36bn | us-gaap:Revenues |
| Research and development | 3 months2019-01-01 to 2019-03-31 | $728.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2019-01-01 to 2019-03-31 | $2.00bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2019-01-01 to 2019-03-31 | $2.04bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2019-01-01 to 2019-03-31 | $431.0m | us-gaap:InterestExpense |
| Income tax | 3 months2019-01-01 to 2019-03-31 | $397.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2019-01-01 to 2019-03-31 | $1.35bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2019-01-01 to 2019-03-31 | $1.56 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2019-01-01 to 2019-03-31 | $1.58 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2019-01-01 to 2019-03-31 | 860,700,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2019-01-01 to 2019-03-31 | $1.50bn | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 3 months2019-01-01 to 2019-03-31 | $363.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 3 months2019-01-01 to 2019-03-31 | $609.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months2019-01-01 to 2019-03-31 | $29.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2019-03-31 | $6.24bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-03-31 | $35.40bn | us-gaap:AssetsCurrent |
| Total assets | At period end2019-03-31 | $137.38bn | us-gaap:Assets |
| Current liabilities | At period end2019-03-31 | $31.40bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2019-03-31 | $95.33bn | us-gaap:Liabilities |
| Short-term borrowings | At period end2019-03-31 | $1.11bn | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2019-03-31 | $39.74bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2019-03-31 | 862,291,415 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000101829-19-000016. Last ingested by Listed: Nov 3, 2026, 21:25 ET. Listed shows no prices and gives no investment advice.